149 related articles for article (PubMed ID: 12093797)
1. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability.
Eberhardt W; Akool el-S; Rebhan J; Frank S; Beck KF; Franzen R; Hamada FM; Pfeilschifter J
J Biol Chem; 2002 Sep; 277(36):33518-28. PubMed ID: 12093797
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells.
Eberhardt W; Beeg T; Beck KF; Walpen S; Gauer S; Böhles H; Pfeilschifter J
Kidney Int; 2000 Jan; 57(1):59-69. PubMed ID: 10620188
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
4. PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.
Cernuda-Morollón E; Rodríguez-Pascual F; Klatt P; Lamas S; Pérez-Sala D
J Am Soc Nephrol; 2002 Sep; 13(9):2223-31. PubMed ID: 12191966
[TBL] [Abstract][Full Text] [Related]
5. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors.
Eberhardt W; Schulze M; Engels C; Klasmeier E; Pfeilschifter J
Mol Endocrinol; 2002 Aug; 16(8):1752-66. PubMed ID: 12145332
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of the cytokine-induced MMP-9/TIMP-1 protease-antiprotease system by the mTOR inhibitor rapamycin.
Osman B; Akool el-S; Doller A; Müller R; Pfeilschifter J; Eberhardt W
Biochem Pharmacol; 2011 Jan; 81(1):134-43. PubMed ID: 20854798
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
[TBL] [Abstract][Full Text] [Related]
10. PPARalpha activators inhibit tissue factor expression and activity in human monocytes.
Marx N; Mackman N; Schönbeck U; Yilmaz N; Hombach V; Libby P; Plutzky J
Circulation; 2001 Jan; 103(2):213-9. PubMed ID: 11208679
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element.
François M; Richette P; Tsagris L; Raymondjean M; Fulchignoni-Lataud MC; Forest C; Savouret JF; Corvol MT
J Biol Chem; 2004 Jul; 279(27):28411-8. PubMed ID: 15090544
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR.
Akool el-S; Kleinert H; Hamada FM; Abdelwahab MH; Förstermann U; Pfeilschifter J; Eberhardt W
Mol Cell Biol; 2003 Jul; 23(14):4901-16. PubMed ID: 12832476
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.
Marrapodi M; Chiang JY
J Lipid Res; 2000 Apr; 41(4):514-20. PubMed ID: 10744771
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Takano H; Nagai T; Asakawa M; Toyozaki T; Oka T; Komuro I; Saito T; Masuda Y
Circ Res; 2000 Sep; 87(7):596-602. PubMed ID: 11009565
[TBL] [Abstract][Full Text] [Related]
18. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells.
Kunz D; Walker G; Eberhardt W; Messmer UK; Huwiler A; Pfeilschifter J
J Clin Invest; 1997 Dec; 100(11):2800-9. PubMed ID: 9389745
[TBL] [Abstract][Full Text] [Related]
20. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
Teruel T; Clapham JC; Smith SA
Biochem Biophys Res Commun; 1999 Oct; 264(2):311-5. PubMed ID: 10529360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
